Article
A prospective study of circulating mutant <i>KRAS2</i> in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up
2003-06-01
Abstract excerpt
<b>Background and aims:</b> Mutant tumour derived DNA has been detected in the sera of colorectal cancer patients. We investigated if mutant serum <i>KRAS2</i> was detectable preoperatively in a large group of patients with colorectal neoplasia. A prospective study of 94 patients who underwent putative curative resection for colorectal carcinoma (CRC) was performed to ascertain if serum mutant <i>KRAS2</i> could b...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4d38f10e-fbf6-55a0-8a8c-21255ed4cc91
- DOI
- 10.1136/mp.56.3.172
